dr. lorenza rimassa on tivantinib for egfr inhibitor-resistant mcrc
Published 9 years ago • 747 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
13:02
3mensio ct pre-case planning: valve-in-valve tavr in perimount 2700
-
0:44
professor veronique leblond - differences in patient prognosis for cll
-
1:26:49
current treatment options for fibrolamellar carcinoma - webinar - 25 feb 2021
-
14:21
3mensio ct pre-case planning: valve-in-valve tavr in mosaic
-
6:25
imc-f106c, a novel prame × cd3 immtac, in metastatic cutaneous melanoma
-
0:33
at a particular temperature, a 3.0 -l flask contains 2.4 moles of cl_2, 1.0 mole of …
-
5:02
third-line treatment options for mcrc
-
0:29
appel
-
10:49
btk degrader offers promise in relapsed and refractory cll
-
3:21
melanoma with liver metastases treatment
-
30:39
extracellular vesicles as communicators between cells - a role in cancer dissemination
-
1:14
lecocq: mam'zelle angot (arr. jacob) - no. 3, mazurka
-
![cellular uptake and fate of fibroin microspheres in 3t3 cells - video s1 [103830]](https://i.ytimg.com/vi/Gb_UPEqLpN8/mqdefault.jpg)
0:08
cellular uptake and fate of fibroin microspheres in 3t3 cells - video s1 [103830]
-
6:38
risk-adapted modulation through de-intensification of cancer treatments
-
24:56
3d fluid-dynamic ovarian cancer model resembling (full title in description)
-
1:44
dr. koprivnikar discusses flt3 inhibitors in hematologic malignancies
-
5:02
european committee of the regions - 113th plenary session – highlights
-
0:33
61-64 find the points on the given curve where the tangent line is horizontal or vertical. r=3 cos…
-
15:41
euronanomed projects of the cofunded call 2017
-
4:02
unmet needs and future direction in aml
-
2:28
governing a multi-level europe (comittee of the regions, 2 december 2014)
-
3:32
efficacy and tolerability results from a phase i/ii study of loxo-305 in b-cell malignancies